Correlation Between IO Biotech and Pmv Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IO Biotech and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IO Biotech and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IO Biotech and Pmv Pharmaceuticals, you can compare the effects of market volatilities on IO Biotech and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IO Biotech with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IO Biotech and Pmv Pharmaceuticals.

Diversification Opportunities for IO Biotech and Pmv Pharmaceuticals

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between IOBT and Pmv is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding IO Biotech and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and IO Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IO Biotech are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of IO Biotech i.e., IO Biotech and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between IO Biotech and Pmv Pharmaceuticals

Given the investment horizon of 90 days IO Biotech is expected to generate 2.21 times more return on investment than Pmv Pharmaceuticals. However, IO Biotech is 2.21 times more volatile than Pmv Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.47 per unit of risk. If you would invest  88.00  in IO Biotech on January 10, 2025 and sell it today you would earn a total of  0.00  from holding IO Biotech or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

IO Biotech  vs.  Pmv Pharmaceuticals

 Performance 
       Timeline  
IO Biotech 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in IO Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, IO Biotech may actually be approaching a critical reversion point that can send shares even higher in May 2025.
Pmv Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pmv Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in May 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

IO Biotech and Pmv Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IO Biotech and Pmv Pharmaceuticals

The main advantage of trading using opposite IO Biotech and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IO Biotech position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.
The idea behind IO Biotech and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities